Maverick Total Disc Replacement in a 'Real World' Patient Population
NCT ID: NCT01338493
Last Updated: 2016-01-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
139 participants
OBSERVATIONAL
2009-02-28
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MAVERICK™ Total Disc Replacement- Pivotal Study
NCT00635843
A-MAV™ Anterior Motion Segment Replacement
NCT00635934
Clinical Trial Comparing Decompression With and Without Coflex™ Interlaminar Technology Treating Lumbar Spinal Stenosis
NCT01316211
LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE
NCT00389597
Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease
NCT03077516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lumbar spinal arthroplasty + Maverick™
Patients requiring total disc replacement
lumbar spinal arthroplasty + Maverick™
All patients will be subjected to a lumbar spinal arthroplasty. The anterior lumbar spine is approached through either a transperitoneal or retroperitoneal exposure. A complete anterior discectomy is performed and the Maverick™ Artificial Disc System is inserted to replace the damaged lumbar intervertebral disc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lumbar spinal arthroplasty + Maverick™
All patients will be subjected to a lumbar spinal arthroplasty. The anterior lumbar spine is approached through either a transperitoneal or retroperitoneal exposure. A complete anterior discectomy is performed and the Maverick™ Artificial Disc System is inserted to replace the damaged lumbar intervertebral disc.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Foraminal stenosis due to loss of disc height
* Back pain and/or leg pain.
Exclusion Criteria
* Posterior facet joint damage and/or disease at the affected level, including facet osteoarthritis, pars fracture and prior laminectomy
* Obesity
* Osteoporosis
* Metallic allergy to cobalt-chromium-molybdenum alloys
* Psychosis
* Infection
* Spinal canal stenosis
* Overlying thoracolumbar kyphosis
* Systemic infection or infection at the site of surgery
* Osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
* Diseases of bone metabolism
* Pregnancy
* Signs of local inflammation
* Fever or Leukocytosis
* Grossly distorted anatomy caused by congenital abnormalities
* Any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery, such as the presence of congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood count (WBC), or a marked left shift in the WBC differential count (this also includes: spinal active oncology pathology; not healed fracture at treated or adjacent level)
* Any case where the implants or components selected would be too large or too small to achieve a successful result
* Any patient in which implant utilization would interfere with anatomical structures or expected physiological performance
* Any patient unwilling to follow postoperative instructions.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Spinal and Biologics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Charles Le Huec, Prof.
Role: PRINCIPAL_INVESTIGATOR
CHU Pellegrin Tripode
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montreal General Hospital
Québec, , Canada
CHU Pellegrin Tripode
Bordeaux, , France
CH Antoine Béclère - Service de Chirurgie Orthopédique
Clamart, , France
Service de Chirurgie Orthopédique, AP-HP, Hôpital Beaujon
Clichy, , France
Clinique de Neurochirurgie Hôpital Roger Salengro
Lille, , France
CH La Timone
Marseille, , France
CH de Meulan - Service de Chirurgie Orthopédique
Meulan-en-Yvelines, , France
Service de Neurochirurgie Hôpital Nice
Nice, , France
CH Lariboisière, Service de Neurochirurgie
Paris, , France
Clinique du Cours Dillon
Toulouse, , France
Charité Berlin - Klinik für Orthopädie
Berlin, , Germany
Universitätsklinikum Magdeburg
Magdeburg, , Germany
Praxis für Orthopädie und Neurochirurgie Potsdam
Potsdam, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Maverick Global Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.